Clinical Report: Effects of Parakinesia Brachialis Oscitans on Upper Limb Recovery
Overview
This study investigates the impact of parakinesia brachialis oscitans (PBO) on motor recovery in ischemic stroke patients. Results indicate that patients with PBO exhibit significantly better recovery outcomes at 3 months compared to those without PBO.
Background
Ischemic stroke is a leading cause of disability, with a significant proportion of survivors facing upper limb motor impairments. Understanding factors that influence recovery, such as PBO, may help tailor rehabilitation strategies. This study aims to clarify the prognostic significance of PBO in stroke recovery.
Data Highlights
Group
FMA Score Mean Difference
Lovett Grades p-value
PBO vs Non-PBO
3.77 (95% CI: −0.54–6.97)
0.018
PBO Disappearance vs Persistence
7.11 (95% CI: −13.10–-1.06)
0.111
Key Findings
Patients with PBO showed higher FMA scores at 3 months compared to non-PBO patients (p = 0.022).
The Lovett classification also indicated better outcomes for the PBO group (p = 0.018).
Among PBO patients, those with early resolution of PBO had significantly better FMA scores than those with persistent PBO (p = 0.021).
Lovett grades did not significantly differ between PBO disappearance and persistence groups (p = 0.111).
PBO may serve as a potential prognostic indicator for motor recovery post-stroke.
Clinical Implications
The presence of PBO may indicate a more favorable prognosis for motor recovery in stroke patients. Clinicians should consider monitoring PBO as part of the assessment process to optimize rehabilitation strategies and interventions.
Conclusion
PBO is associated with improved motor recovery outcomes in ischemic stroke patients, suggesting its potential as a prognostic marker. Further prospective studies are warranted to validate these findings.
